• Blog
  • Topical Pain Relief Market Report

    Topical Pain Relief Market Report

    Topical Pain Relief Market Report
    Report code - SRHL267 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Topical Pain Relief Market, Dynamics, and Market Analysis
    See more...

    Impact of COVID-19 on Topical Pain Relief Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Topical Pain Relief Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Global Topical Pain Relief Market was valued at USD 8.82 billion in 2020 and is likely to reach USD 12.61 billion by 2026 at a CAGR of over 6.1% during the forecast period.

    Figure: Global Topical Pain Relief Market Size, 2020-2026 (USD Billion)

    Topical-Pain-Relief-Market-Forecast

    Wish to know more about the report? Click here to get a free sample.

    What is Topical Pain Relief?

    Topical pain relief medicines are directly applied to the epidermal layer of the skin in the area of pain or inflammation. These topical pain relief products are mainly developed to relieve pain and use the skin as the medium for drug administration and exert major action at the specific skin site and in the central nervous system.

    Moreover, these chemical formulations are anesthetic or analgesic agents, which are applied on or around the painful site. The main focus is to provide a slow and gradual release of pain relief medication into the bloodstream by keeping the blood levels relatively constant for some time.

    Key Players

    Key players operating in the global topical pain relief market are-

    • Johnson & Johnson (The U.S),
    • Novartis AG (Switzerland),
    • GlaxoSmithKline Plc. (UK),
    • Pfizer Inc. (The U.S),
    • Reckitt Benckiser Group Plc. (UK),
    • Sanofi S.A. (France),
    • Topical BioMedics, Inc. (The U.S),
    • AdvaCare Pharma (India),
    • Sun Pharmaceutical Industries Ltd. (India), and
    • Nestle S.A. (Switzerland).

    Market Dynamics

    The growing prevalence of arthritis and other bone-related medical conditions, and diabetic neuropathy results in pain, thereby act as a key driver.

    • The surge in the adoption of topical pain relief products due to fewer side effects in comparison to oral pain relief drugs, rise in the need for topical pain relief among sportsmen, and growing geriatric population worldwide are other factors augmenting the market growth.
    • However, this pain relief formulation can result in irritated skin and it also possesses a strong odor, thus can create a hindrance to the market expansion.

    Segment Analysis

    Therapeutic Class Trends

    By therapeutic class, the topical pain relief market has been bifurcated into non-opioids and opioids.

    • Under these, the non-opioids segment held the largest market share in 2020 and is projected to register a healthy CAGR during the review period.
    • This is mainly attributed to its high preference over opioid drugs for treating mild to moderate pain.
    • Also, it has relatively fewer side effects in comparison to opioids, further boosts the segment growth.

    Regional Trends

    By region, the North America market garnered the largest market share in 2020 and is likely to grow at a steady CAGR during the assessment period.

    • This is mainly ascribed to increasing adoption of over-the-counter pain relief products and early approval of topical pain relief medications in this region.
    • Also, the presence of major product manufacturers in the region further boosts the regional market growth.

    COVID-19 Impact on Global Topical Pain Relief Market

    The outbreak of the COVID-19 virus has substantially affected the topical pain relief industry. A large number of clinics and pain services have witnessed a significant decline in the number of patient visits during the pandemic. In addition, most chronic pain services were considered non-urgent, both elective interventional and outpatient procedures were partially shut down or completely stopped during the COVID-19 period to curb the risk of the viral spread.

    Critical Questions Answered in the Report

    • What are the key trends in the global topical pain relief market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global topical pain relief market?
    • What are the key strategies adopted by the major vendors to lead in the global topical pain relief market?
    • What is the market share of the top vendors?

    To know about the assumptions related to the report. Register Here

    Target Audience

    The following is a list of the customers that the Topical Pain Relief market aims to convert the most:

    • Topical pain relief companies
    • Topical pain relief vendors
    • R&D companies
    • Hospitals
    • Drug manufacturing companies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    The topical pain relief market size is expected to reach USD 12.61 billion in the foreseeable future.

    Johnson & Johnson (The U.S), Novartis AG (Switzerland), GlaxoSmithKline Plc. (UK), Pfizer Inc. (The U.S), Reckitt Benckiser Group Plc. (UK), Sanofi S.A. (France), Topical BioMedics, Inc. (The U.S), AdvaCare Pharma (India), Sun Pharmaceutical Industries Ltd. (India) and Nestle S.A. (Switzerland) are among the key players in the topical pain relief market.

    The topical pain relief market is expected to witness an impressive growth of 6.1% CAGR in the coming years.

    North America garnered the largest share in topical pain relief market in 2020.

    The non-opioids segment is expected to register a healthy CAGR in the topical pain relief market in the coming years.

    Growing prevalence of arthritis and other bone-related medical conditions, surge in the adoption of topical pain relief products due to fewer side effects in comparison to oral pain relief drugs, rise in the need for topical pain relief among sportsmen, and growing geriatric population worldwide are the factors driving the growth of topical pain relief market.

    Topical pain relief companies, Topical pain relief vendors, R&D companies, Hospitals, Drug manufacturing companies are the target audience in the topical pain relief market.

    •